Klotzbach J M, Diamond G L
Department of Pharmacology and Environmental Health Sciences Center, School of Medicine and Dentistry, University of Rochester, New York 14642.
Am J Physiol. 1988 Jun;254(6 Pt 2):F871-8. doi: 10.1152/ajprenal.1988.254.6.F871.
The renal handling of the heavy metal complexing agent, 2,3-dimercapto-1-propane sulfonate (DMPS), was examined in the isolated perfused rat kidney (IPRK). Net tubular secretion of DMPS was saturable and blocked by p-aminohippuric acid (PAH) and probenecid (PRB), indicating involvement of carrier-mediated transport in the excretion of DMPS. DMPS was oxidized to a disulfide form (DMPSS) in perfusate and reduced to a sulfhydryl form (DMPSH) in kidney. In kidneys isolated from rats pretreated with HgCl2, DMPS produced a dose-dependent decrease in retention of inorganic mercury, an increase in urinary excretion of mercury, and an increase in the amount of mercury transferred from kidney into venous perfusate. At a maximally effective dose, 40% of the renal mercury content was excreted in urine during 30 min of perfusion. Urinary excretion of mercury induced by DMPS was completely blocked by concentrations of PRB that blocked tubular secretion of DMPS and decreased uptake of DMPS in kidney. Thus tubular secretion of DMPS and reduction of DMPSS to DMPSH are important in the renal handling of DMPS and may contribute to the activity of DMPS as a complexing agent for renal mercury.
在离体灌注大鼠肾脏(IPRK)中研究了重金属络合剂2,3-二巯基-1-丙烷磺酸盐(DMPS)的肾脏处理情况。DMPS的肾小管净分泌是可饱和的,并且被对氨基马尿酸(PAH)和丙磺舒(PRB)阻断,这表明载体介导的转运参与了DMPS的排泄。DMPS在灌注液中被氧化为二硫化物形式(DMPSS),在肾脏中被还原为巯基形式(DMPSH)。在从用HgCl2预处理的大鼠分离的肾脏中,DMPS使无机汞的潴留呈剂量依赖性降低,汞的尿排泄增加,并且从肾脏转移到静脉灌注液中的汞量增加。在最大有效剂量下,在30分钟的灌注过程中,40%的肾脏汞含量通过尿液排出。DMPS诱导的汞尿排泄被阻断DMPS肾小管分泌并降低肾脏中DMPS摄取的PRB浓度完全阻断。因此,DMPS的肾小管分泌以及DMPSS还原为DMPSH在DMPS的肾脏处理中很重要,并且可能有助于DMPS作为肾脏汞络合剂的活性。